Drugs / AIDSVAX B/E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01964937 | ? → Apr 2014 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964937 ↗ |
| Modality | Vaccine | “The AIDSVAX B/E ® vaccine” NCT01964937 ↗ |
| Route | Intramuscular | “will be administered as a 1 mL/600 mcg dose IM” NCT01964937 ↗ |